Siemens Healthineers.:企業の戦略・SWOT・財務情報

◆英語タイトル:Siemens Healthineers. - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C13655
◆発行会社(調査会社):MarketLine
◆発行日:2019年2月
◆ページ数:48
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ドイツ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Siemens Healthineers. – Strategy, SWOT and Corporate Finance Report
Summary

Siemens Healthineers. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Siemens Healthineers (Siemens or ‘the company’), formerly known as Siemens Healthcare, is engaged in manufacturing, developing and marketing of clinical diagnostics and therapeutic systems. The company’s products portfolio includes medical imaging, ultrasound, point of care testing, healthcare IT, clinical specialties and diseases, and laboratory diagnostics systems and devices. It also provides services such as customer services, enterprise services, laboratory diagnostics services and option and upgrade services. It operates through its subsidiaries in Americas, Europe, Commonwealth of Independent States (C.I.S.), Africa, Middle East and Asia, Australia. Siemens is headquartered in Erlangen, Bayern, Germany

Scope

- Detailed information on Siemens Healthineers. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Siemens Healthineers. in the form of a SWOT analysis
- An in-depth view of the business model of Siemens Healthineers. including a breakdown and examination of key business segments
- Intelligence on Siemens Healthineers.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Siemens Healthineers., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Siemens Healthineers. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Siemens Healthineers. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Siemens Healthineers.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Siemens Healthineers.: Company Overview
Siemens Healthineers.: Overview and Key Facts
Siemens Healthineers.: Overview
Siemens Healthineers.: Key Facts
Siemens Healthineers.: Key Employees
Siemens Healthineers.: Key Employee Biographies
Siemens Healthineers.: Major Products and Services
Siemens Healthineers.: Company History
Siemens Healthineers.: Locations and Subsidiaries
Siemens Healthineers.: Key Competitors
Siemens Healthineers.: Company Analysis
Siemens Healthineers.: Business Description
Siemens Healthineers.: SWOT Analysis
Siemens Healthineers.: SWOT Overview
Siemens Healthineers.: Strengths
Siemens Healthineers.: Weaknesses
Siemens Healthineers.: Opportunities
Siemens Healthineers.: Threats
Siemens Healthineers.: Corporate Financial Deals Activity
Siemens Healthineers.: Financial Deals Overview
Siemens Healthineers.: Targets and Partners
Siemens Healthineers.: Top Deals 2015 – 2019YTD*
Siemens Healthineers.: Mergers and Acquisitions
Siemens Healthineers.: Corporate Venturing
Siemens Healthineers.: Partnership
Siemens Healthineers.: Divestments
Siemens Healthineers.: Recent Developments
Siemens Healthineers.: News and Events Summary
Siemens Healthineers.: Business Expansion
Siemens Healthineers.: Contracts
Siemens Healthineers.: Market Developments
Siemens Healthineers.: Research & Development
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Siemens Healthineers.: Key Facts
Table 2: Siemens Healthineers.: Key Employees
Table 3: Siemens Healthineers.: Company History
Table 4: Siemens Healthineers.: Locations and Subsidiaries
Table 5: Siemens Healthineers.: Key Competitors
Table 6: Siemens Healthineers.: Deal Activity by Deal Type - Volume (TTM*)
Table 7: Siemens Healthineers.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Table 8: Siemens Healthineers.: Targets and Partners
Table 9: Siemens Healthineers.: Top Deals 2015 - 2019YTD*
Table 10: Siemens Healthineers.: M&A Volume and Value Trend (2015 - YTD*2019)
Table 11: Siemens Healthineers.: M&A Activity by Geography (2015 - YTD*2019)
Table 12: Siemens Healthineers.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Table 13: Siemens Healthineers.: Corporate Venturing by Geography (2015 - YTD*2019)
Table 14: Siemens Healthineers.: Partnership Volume and Value Trend (2015 - YTD*2019)
Table 15: Siemens Healthineers.: Partnership Trend by Deal Type (2015 - YTD*2019)
Table 16: Siemens Healthineers.: Divestments Volume and Value Trend (2015 - YTD*2019)
Table 17: Siemens Healthineers.: News and Events Summary
Table 18: Siemens Healthineers.: Business Expansion
Table 19: Siemens Healthineers.: Contracts
Table 20: Siemens Healthineers.: Market Developments
Table 21: Siemens Healthineers.: Research & Development

List of Figures
Figure 1: Siemens Healthineers.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Siemens Healthineers.: Deal Activity by Deal Type - Volume (2015 - YTD*2019)
Figure 3: Siemens Healthineers.: M&A Volume and Value Trend (2015 - YTD*2019)
Figure 4: Siemens Healthineers.: M&A Activity by Geography (2015 - YTD*2019)
Figure 5: Siemens Healthineers.: Corporate Venturing Volume and Value Trend (2015 - YTD*2019)
Figure 6: Siemens Healthineers.: Corporate Venturing by Geography (2015 - YTD*2019)
Figure 7: Siemens Healthineers.: Partnership Volume and Value Trend (2015 - YTD*2019)
Figure 8: Siemens Healthineers.: Partnership Trend by Deal Type (2015 - YTD*2019)
Figure 9: Siemens Healthineers.: Divestments Volume and Value Trend (2015 - YTD*2019)

★海外企業調査レポート[Siemens Healthineers.:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Celsius Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Celsius Therapeutics Inc (Celsius Therapeutics) is a biotechnology company that carries out single-cell genomic analysis to discover and develop precision medicines for autoimmune diseases and cancer. The company’s drug discovery is based on understanding specific cells that play a major rol …
  • Zetro Aerospace Corporation Sdn. Bhd.:企業の戦略・SWOT・財務情報
    Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report Summary Zetro Aerospace Corporation Sdn. Bhd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analy …
  • Citius Pharmaceuticals Inc (CTXR)-製薬・医療分野:企業M&A・提携分析
    Summary Citius Pharmaceuticals Inc (Citius), formerly Trail One Inc, is a specialty pharmaceutical company that focused on the development and commercialization of adjunctive cancer care and critical care drug products. The company‘s proprietary product candidates include mino-lok, an antibiotic loc …
  • Oil States International Inc (OIS):企業の財務・戦略的SWOT分析
    Oil States International Inc (OIS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Varian Medical Systems Inc (VAR)-製薬・医療分野:企業M&A・提携分析
    Summary Varian Medical Systems Inc (Varian) designs, manufactures and sells equipment and software for the diagnosis and treatment of cancer and other medical conditions through radiotherapy, radiosurgery, proton therapy and brachytherapy. Its major products include brachytherapy afterloaders, linea …
  • AcelRx Pharmaceuticals Inc (ACRX)-医療機器分野:企業M&A・提携分析
    Summary AcelRx Pharmaceuticals Inc (AcelRx), is a specialty pharmaceutical company that develops and commercializes novel therapies for the treatment of pain. The company’s lead product candidate, DSUVIA (known as ARX-04 outside the US), is a single sufentanil sublingual tablet for the treatment of …
  • Bloomsbury Publishing Plc (BMY):企業の財務・戦略的SWOT分析
    Bloomsbury Publishing Plc (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weak …
  • ALK-Abello AS (ALK B)-製薬・医療分野:企業M&A・提携分析
    Summary ALK-Abello A/S (ALK) is a research-oriented pharmaceutical company, which discovers, develops and commercializes immunotherapies for allergy prevention and treatment. It also markets diagnostics and other services to allergy clinics. The company's allergy immunotherapy product portfolio incl …
  • Fabric Genomics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fabric Genomics Inc (Fabric), formerly Omicia Inc, is a healthcare solutions provider that offers genome interpretation solutions. The company offers Opal, a cloud-based informatics platform that helps to analyze and interpret genomes by prioritizing disease-causing variants and genes. Fabri …
  • Kadimastem Ltd (KDST):製薬・医療:M&Aディール及び事業提携情報
    Summary Kadimastem Ltd (Kadimastem) is a clinical stage biopharmaceutical company that develops industrial regenerative medicines to treat neuro-degenerative diseases. Its technology platform enables the manufacturing of islet-like endocrine cells (differentiated cells) and glia restricted progenito …
  • Mitsubishi Chemical Corp:企業の戦略的SWOT分析
    Mitsubishi Chemical Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • Covagen AG-製薬・医療分野:企業M&A・提携分析
    Summary Covagen AG (Covagen), a subsidiary of Cilag GmbH International is a biopharmaceutical company specializing in the development of multispecific protein therapeutics through the FynomAb technology. The company’s pipeline products include COVA 322, a bispecific anti-tumor necrosis factor alpha …
  • PolyPid Ltd-医療機器分野:企業M&A・提携分析
    Summary PolyPid Ltd (PolyPid) is a clinical stage pharmaceutical company that develops, manufactures and commercialize drugs for extended release and local delivery. The company develops its products using PLEX (Polymer-Lipid Encapsulation MatriX) platform, which helps in products. PolyPid’s pipelin …
  • United Cooperative Services Inc:企業の戦略的SWOT分析
    United Cooperative Services Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Lytron Inc.:企業の戦略・SWOT・財務情報
    Lytron Inc. - Strategy, SWOT and Corporate Finance Report Summary Lytron Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Xylem Inc (XYL):企業の財務・戦略的SWOT分析
    Xylem Inc (XYL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • Infinity Pharmaceuticals Inc (INFI):企業の財務・戦略的SWOT分析
    Infinity Pharmaceuticals Inc (INFI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and …
  • Nestle Health Science SA:製薬・医療:M&Aディール及び事業提携情報
    Summary Nestle Health Science SA (Nestle Health), a subsidiary of Nestle SA, is a health science company that manufactures nutritional and medicinal products derived from botanical plants. The company provides nutritional therapies for chronic conditions related to gastrointestinal diseases, aging p …
  • HD Supply Inc:企業の戦略的SWOT分析
    HD Supply Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Vipul Ltd.:戦略・SWOT・企業財務分析
    Vipul Ltd. - Strategy, SWOT and Corporate Finance Report Summary Vipul Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆